Browse All
Displaying 1 - 1 of 1
Author:Boer, Ibolya Cree, Bruce Wiendl, Heinz Cross, Anne Delgado, Sylvia Habek, Mario Khachanova, Natalia Ward, Brian Totolyan, Natalia Mancione, Linda Sullivan, Roseanne Zielman, Ronald Hu, Xixi Das Gupta, Ayan Montalban, Xavier Winthrop, Kevin
Session Name:P1: Multiple Sclerosis: Clinical Practice and Decision Making 1
Topic:Multiple Sclerosis
Program Number:P1.010
Author Institution:Novartis Pharma AG, Basel, Switzerland UCSF Weill Institute for Neurosciences, Department of Neurology, University of California San Francisco, San Francisco, CA Department of Neurology with Institute of Translational Neurology, University of Münster, Muenster, Germany Washington University School of Medicine, Saint Louis, MO University of Miami Miller School of Medicine, Miami, FL University Hospital Center Zagreb, University of Zagreb, School of Medicine, Zagreb, Croatia Pirogov Russian National Research Medical University, Moscow, Russian Federation Infectious Diseases Division, Research Institute of the McGill University Health Centre, Montreal, QC, Canada First Saint Petersburg State Medical University, St Petersburg , Russian Federation Novartis Pharmaceuticals Corporation, East Hanover, NJ Novartis Pharma B.V, Amsterdam, Netherlands Novartis Healthcare Private Limited, Hyderabad, India Department of Neurology-Neuroimmunology, Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Hospital Universitari Vall d'Hebron, Barcelona, Spain School of Public Health at Oregon Health & Science University, Portland, OR
